Genomic and Expression Analysis of the 8p11-12 Amplicon in Human Breast Cancer Cell Lines

Cancer Research

Volumn 64, Issue 1, 2004, Pages 40-47

  Ray, Michael E ^a   Yang, Zeng Quan ^a   Albertson, Donna ^b   Kleer, Celina G ^a   Washburn, Joseph G ^a   Macoska, Jill A ^a   Ethier, Stephen P ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c 7312 CCGC ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 2; MYC PROTEIN; RNA;

AMPLICON; ARTICLE; BREAST CANCER; CHROMOSOME 8P; DNA MICROARRAY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENOME; HUMAN; HUMAN CELL; NORTHERN BLOTTING; ONCOGENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

BLOTTING, SOUTHERN; BREAST NEOPLASMS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 8; DNA, COMPLEMENTARY; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENES; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTORS, FIBROBLAST GROWTH FACTOR; TUMOR CELLS, CULTURED;

EID: 1642535541     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-1022     Document Type: Article

References (52)

1. DiFiore, P. P., Pierce, J. H., Fleming, T. P., Hazan, R., Ullrich, A., Richter King, C., Schlessinger, J., and Aaronson, S. A. Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells. Cell, 51: 1063-1070, 1987.
2. Hudziak, R. M., Schlessinger, J., and Ullrich, A. Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells. Proc. Nat. Acad. Sci. USA, 84: 7159-7163, 1987.
3. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., and McGuire, W. L. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (Wash. DC), 235: 177-182, 1987.
4. Kauraniemi, P., Barlund, M., Monni, O., and Kallioniemi, A. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays. Cancer Res., 61: 8235-8240, 2001.
5. Stein, D., Wu, J., Fuqua, S. A. W., Roonprapunt, C., Yajnik, V., Deustachio, P., Moskow, J. J., Buchberg, A. M., Osborne, C. K., and Margolis, B. The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer. EMBO J., 13: 1331-1340, 1994.
6. Adnane, J., Gaudray, P., Dionne, C. A., Crumley, G., Jaye, M., Schlessinger, J., Jeanteur, P., Birnbaum, D., and Theillet, C. BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers. Oncogene, 6: 659-663, 1991.
7. Penault-Llorca, F., Bertucci, F., Adelaide, J., Parc, P., Coulier, F., Jacquemier, J., Birnbaum, D., and Delapeyriere, O. Expression of FGF and FGF receptor genes in human breast cancer. Int. J. Cancer. 61: 170-176. 1995.
8. Tannheimer, S. L., Rehemetulla, A., and Ethier, S. P. Characterization of fibroblast growth factor receptor 2 overexpression in the SUM-52 human breast cancer cell line. Breast Cancer Res., 2: 311-320, 2000.
9. Theillet, C., Adelaide, J., Louason, G., Bonnet-Dorion, F., Jacquemier, J., Adnane, J., Longy, M., Katsaros, D., Sismondi, P., and Baudray, P. FGFR1 and PLAT genes and DNA amplification at 8p12 in breast and ovarian cancers. Genes Chromosomes Cancer, 7: 219-226, 1993.
10. Ugolini, F., Adelaide, J., Charafe-Jauffret, E., Nguyen, C., Jacquemier, J., Jordan, B., Birnbaum, D., and Pebusque, M. J. Differential expression assay of chromosome arm 8p genes identifies Frizzled-related (FRP1/FRZB) and Fibroblast Growth Factor Receptor 1 (FGFR1) as candidate breast cancer genes. Oncogene, 18: 1903-1910, 1999.
11. Cuny, M., Kramar, A., Courjal, F., Johannsdottir, V., Iacopetta, B., Fontaine, H., Grenier, J., Culine, S., and Theillet, C. Relating genotype and phenotype in breast cancer: an analysis of the prognostic significance of amplification at eight different genes or loci and of p50 mutations. Cancer Res., 60: 1077-1083, 2000.
12. Courjal, F., Cuny, M., Simony-Lafontaine, J., Louason, G., Speiser, P., Zeillinger, R., Rodriguez, C., and Theillet, C. Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups. Cancer Res., 57: 4360-4367, 1997.
13. Dib, A., Adelaide, J., Chaffanet, M., Imbert, A., Lepaslier, D., Jacquemier, J., Gaudray, P., Theillet, C., Birnbaum, D., and Pebusque, M. J. Characterization of the region of the short arm of chromosome 8 amplified in breast carcinoma. Oncogene, 10: 995-1001, 1995.
14. Forozan, F., Veldman, R., Ammerman, C. A., Parsa, N. Z., Kallioniemi, A., Kallioniemi, O., and Ethier, S. P. Molecular cytogenetic analysis of 11 new human breast cancer cell lines. Br. J. Cancer, 81: 1328-1334, 1999.
15. Forozan, F., Mahlamaki, E. H., Monni, O., Chen, Y., Veldman, R., Jiang, Y., Gooden, G., Ethier, S. P., Kallioniemi, A., and Kallioniemi, O-P. CGH analysis of 38 breast cancer cell lines: A basis for interpreting cDNA mircroarray data. Cancer Res., 60: 4519-4525, 2000.
16. Snijders, A. M., Nowak, N., Segraves, R., Blackwood, S., Brown, N., Conroy, J., Hamilton, G., Hindle, A. K., Huey, B., Kimura, K., Law, S., Myambo, K., Palmer, J., Ylstra, B., Yue, J. P., Gray, J. W., Jain, A. N., Pinkel, D., and Albertson, D. G. Assembly of microarrays for genome-wide measurement of DNA copy number. Nat. Genet., 29: 263-264, 2001.
17. Snijders, A. M., Fridlyand, J., Mans, D. A., Segraves, R., Jain, A. N., Pinkel, D., and Albertson, D. G. Shaping of tumor and drug-resistant genomes by instability and selection. Oncogene, 22: 4370-4379. 2003.
18. Pinkel, D., Segraves, R., Sudar, D., Clark, S., Poole, I., Kowbel, D., Collins, C., Kuo, W-L., Chen, C., Zhai, Y., Dairkee, S. H., Ljung, B-M., Gray, J. W., and Albertson, D. G. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat. Genet., 20: 207-211, 1998.
19. Jain, A. N., Tokuyasu, T. A., Snijders, A. M., Segraves, R., Albertson, D. G., and Pinkel, D. Fully automatic quantification of microarray image data. Genome Res., 12: 325-332, 2002.
20. Ethier, S. P., Mahacek, M. L., Gullick, W. J., Frank, T. J., and Weber, B. L. Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media. Cancer Res., 53: 627-635, 1993.
21. Ethier, S. P. Human breast cancer cell lines as models of growth regulation and disease progression. J. Mamm. Gland Biol. Neoplasia, 1: 111-121, 1996.
22. Pauley, R. J., Soule, H. D., Tait, L., Miller, F. R., Wolman, S. R., Dawson, P. J., and Heppner, G. H. The MCF10A family of spontaneously immortalized human breast epithelial cell lines: models of neoplastic progression. Eur. J. Cancer Prev., 2 (Suppl. 3): 67-76, 1993.
23. Mohammadi, M., Froum, S., Hamby, J. M., Schroeder, M. C., Panek, R. L., Lu, G. H., Eliseenkova, A. V., Green, D., Schlessinger, J., and Hubbard, S. R. Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain. EMBO J., 17: 5896-5904, 1998.
24. Chaib, H., MacDonald, J. W., Vessella, R. L., Washburn, J. G., Quinn, J. E., Odman, A., Rubin, M. A., and Macoska, J. A. Haploinsufficiency and reduced expression of genes localized to the 8p chromosomal region in human prostate tumors. Genes Chromosomes Cancer, 37: 306-313, 2003.
25. Deming, S. L., Nass, S. J., Dickson, R. B., and Trock, B. J. C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance. Br. J. Cancer, 83: 1688-1695, 2000.
26. Berns, E. M. J. J., Klijn, J. G. M., van Stavern, I. L., Portengen, H., Noordegraaf, E., and Foekens, J. A. Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: Correlation with steroid receptors. Eur. J. Cancer, 28: 697-700, 1992.
27. Chrzan, P., Skokowski, J., Karmolinski, A., and Pawelczyk, T. Amplification of c-myc gene and overexpression of c-Myc protein in breast cancer and adjacent non-neoplastic tissue. Clin. Biochem., 34: 557-562, 2001.
28. Bonilla, M., Ramirez, M., Lopez-Cueto, J., and Gariglio, P. In vivo amplification and rearrangement of c-myc oncogene in human breast tumors. J. Natl. Cancer Inst., 80: 665-671, 1988.
29. Rummukainen, J. K., Salminen, T., Lundin, J., Kytola, S., Joensuu, H., and Isola, J. J. Amplification of c-myc by fluorescence in situ hybridization in a population-based breast cancer tissue array. Mod. Pathol., 14: 1030-1035, 2001.
30. Anbazhagan, R., Fujii, H., and Gabrielson, E. Allelic loss of chromosomal arm 8p in breast cancer progression. Am. J. Pathol., 152: 815-819, 1998.
31. Kerangueven, F., Essioux, L., Dib, A., Noguchi, T., Allione, F., Geneix, J., Longy, M., Lidereau, R., Eisinger, F., and Pebusque, M. J. Loss of heterozygosity and linkage analysis in breast carcinoma: indication for a putative third susceptibility gene on the short arm of chromosome 8. Oncogene, 10: 1023-1026, 1995.
32. Yaremko, M. L., Recant, W. M., and Westbrook, C. A. Loss of heterozygosity from the short arm of chromosome 8 is an early event in breast cancers. Genes. Chromosomes Cancer, 13: 186-191, 1995.
33. Sigbjornsdottir, B. I., Ragnarsson, G., Agnarsson, B. A., Huiping, C., Barkardottir, R. B., Egilsson, V., and Ingvarsson, S. Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer. J. Med. Genet., 37: 342-347, 2000.
34. Still, I. H., Hamilton, M., Vince, P., Wolfman, A., and Cowell, J. K. Cloning of TACC1, an embryonically expressed, potentially transforming coiled coil containing gene, from the 8p11 breast cancer amplicon. Oncogene, 18: 4032-4038, 1999.
35. Gergely, F. Centrosomal TACCtics. BioEssays, 24: 915-925, 2002.
36. Giet, R., McLean, D., Descamps, S., Lee, M. J., Raff, J. W., Prigent, C., and Glover, D. M. Drosophila Aurora A kinase is required to localize D-TACC to centrosomes and to regulate astral micrombules. J. Cell Biol., 156: 437-451, 2002.
37. Lee, M. J., Gergely, F., Jeffers, K., Peak-Chew, S. Y., and Raff, J. W. Msps/XMAP215 interacts with the centrosomal protein D-TACC to regulate microtubule behaviour. Nat. Cell Biol., 3: 643-649, 2001.
38. Gergely, F., Karlsson, C., Still, I., Cowell, J., Kilmartin, J., and Raff, J. W. The TACC domain identifies a family of centrosomal proteins that can interact with microtubules. Proc. Natl. Acad. Sci. USA. 97: 14325-14357, 2000.
39. Gergely, F., Kidd, D., Jeffers, K., Wakefield, J. G., and Raff, J. W. D-TACC: a novel centrosomal protein required for normal spindle function in the early Drosophila embryo. EMBO J., 19: 241-252, 2000.
40. Conte, N., Charafe-Jauffret, E., Delaval, B., Adelaide, J., Ginestier, C., Geneix, J., Isnardon, D., Jacquemier, J., and Birnbaum, D. Carcinogenesis and translational controls: TACC1 is down-regulated in human cancers and associates with mRNA regulators. Oncogene, 21: 5619-5630, 2002.
41. Chen, H-M., Schmeichel, K. L., Mian, I. S., Lelievre, S., Petersen, O. W., and Bissell, M. J. AZU-1: A candidate breast tumor suppressor and biomarker for tumor progression. Mol. Biol. Cell, 11: 1357-1367, 2000.
42. Schweinfest, C. W., Graber, M. W., Chapman, J. M., Papas, T. S., Baron, P. L., and Watson, D. K. CaSm: an Sm-like protein that contributes to the transformed state in cancer cells. Cancer Res., 57: 2961-2965, 1997.
43. Kelley, J. R., Fraser, M. M., Schweinfest, C. W., Vournakis, J. N., Watson, D. K., and Cole, D. J. CaSm/gemcitabine chemo-gene therapy leads to prolonged survival in a murine model of pancreatic cancer. Surgery (St. Louis), 130: 280-288, 2001.
44. Chua, E. L., Young, L., Wu, W. M., Turtle, J. R., and Dong, Q. Cloning of TC-1 (C8orf4), a novel gene found to be overexpressed in thyroid cancer. Genomics, 69: 342-347, 2000.
45. Porter, D. A., Krop, I. E., Nasser, S., Sgroi, D., Kaelin, C. M., Marks, J. R., Riggins, G., and Polyak, K. A SAGE (serial analysis of gene expression) view of breast tumor progression. Cancer Res., 61: 5697-5702, 2001.
46. Lindsay, A. J., Hendrick, A. G., Cantalupo, G., Senic-Matuglia, F., Goud, B., Bucci, C., and McCaffrey, M. W. Rab coupling protein (RCP), a novel Rab4 and Rab11 effector protein. J. Biol. Chem., 277: 12190-12199, 2002.
47. Wallace, D. M., Lindsay, A. J., Hendrick, A. G., and McCaffrey, M. W. The novel Rab11-FIP/Rip/RCP family of proteins displays extensive homo- and hetero-interacting abilities. Biochem. Biophys. Res. Comm., 292: 909-915, 2002.
48. Kerckaert, J. P., Deweindt, C., Tilly, H., Quief, S., Lococq, G., and Bastard, C. LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas. Nat. Genet., 5: 66-70, 1993.
49. Collins, C., Rommens, J. M., Kowbel, D., Godfrey, T., Tanner, M., Hwang, S. I., Polikoff, D., Nonet, G., Cochran, J., Myambo, K., Jay, K. E., Froula, J., Cloutier, T., Kuo, W. L., Yaswen, P., Dairkee, S., Giovanola, J., Hutchinson, G. B., Isola, J., Kallioniemi, O. P., Palazzolo, M., Martin, C., Ericsson, C., Pinkel, D., Gray, J. W., et al. Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma. Proc. Natl. Acad. Sci. USA, 95: 8703-8708, 1998.
50. Kinzler, K. W., Ruppert, J. M., Bigner, S. H., and Vogelstein, B. The GL1 gene is a member of the Kruppel family of zinc finger proteins. Nature (Lond.), 332: 371-374, 1988.
51. Fingar, D. C., Salama, S., Tsou, C., Harlow, E., and Blenis, J. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev., 16: 1472-1487, 2002.
52. Van't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., Schreiber, G. J., Kerkhoven, R. M., Roberts, C., Linsley, P. S., Bernards, R., and Friend, S. H. Gene expression profiling predicts clinical outcome of breast cancer. Nature (Lond.), 415: 530-536, 2002.